microScript microRNA cDNA Synthesis Kit
for the reverse transcription of microRNA from either Total RNA preparations or enriched microRNA preparations
For research use only and NOT intended for in vitro diagnostics.
microScript microRNA cDNA Synthesis Kit
for the reverse transcription of microRNA from either Total RNA preparations or enriched microRNA preparations
Register today to receive an exclusive 15% off* on your first order.
Features and Benefits
- Convenient
- One cDNA Synthesis, Multiple microRNAs and microRNA-targets analyzed
- Time Savings
- Cost Efficient
- High Sensitivity and Yield
- Robust Enzyme
- Available in 12 or 50 reaction size
Norgen's microScript microRNA cDNA Synthesis Kit is an all-in-one, ready-to-use product for the reverse transcription of microRNA from either Total RNA preparations or enriched microRNA preparations. The kit contains the 2x Reaction Mix and the microScript microRNA Enzyme Mix. The kit utilizes Norgen’s microScript Reverse Transcriptase, a mutant version of Moloney Murine Leukemia Virus (M-MuLV) Reverse Transcriptase. It has reduced RNase H activity and increased thermal stability.
The workflow of Norgen's microScript microRNA cDNA Synthesis Kit involves a simple, single-tube set-up by the mixing of 2x Reaction Mix, Enzyme Mix and the RNA template. The reaction can then be carried out in a thermocycler. A poly (A) tail is first added to the RNA template, followed by cDNA synthesis using an adapter primer. In addition to the ease-of-use, the single-tube set-up provides superb consistency and sensitivity. The cDNA could be used in a PCR or qPCR amplification using a Universal PCR Reverse Primer and the forward primer that contains the sequence of the microRNA of interest. A single cDNA preparation could be used for PCR amplification of a number of different microRNAs. In addition, the cDNA preparation could be used for PCR or qPCR detection (using gene-specific forward and reverse primers) of mRNA or large RNA if total RNA preparation was the starting template. This could allow for parallel evaluation of expression level of microRNAs and microRNA-targets.
Details
Supporting Data
Storage Conditions and Product Stability
This kit is stable for 1 year after the date of shipment .
Component | Cat. 54415 (12 rxns) | Cat. 54410 (50 rxns) |
---|---|---|
microScript microRNA Enzyme Mix | 12 μL | 50 μL |
2x Reaction Mix | 120 μL | 500 μL |
Universal PCR Reverse Primer | 60 μL | 250 μL |
Nuclease-Free Water | 1.25 mL | 2 x 1.25 mL |
Product Insert | 1 | 1 |
Documentation
Citations
Title | Diagnosis of Cutaneous Acute Graft-Versus-Host Disease Through Circulating Plasma miR-638, miR-6511b-5p, miR-3613-5p, miR-455-3p, miR-5787, and miR-548a-3p as Prospective Noninvasive Biomarkers Following Allogeneic Hematopoietic Stem Cell Transplantation |
Citation | Clinical Transplantation 2024. |
Authors | Marzieh Izadifard, Mohammad Ahmadvand, Hossein Pashaiefar, Kamran Alimoghadam, Amir Kasaeian, Maryam Barkhordar, Ghazal Seghatoleslami, Mohammad Vaezi, Ardeshir Ghavamzadeh, Marjan Yaghmaie |
Title | Modulation of microRNA-133B in Post Mastectomy Pain Syndrome Following Yoga Intervention |
Citation | Journal Of Cellular & Molecular Anesthesia 2024. |
Authors | Ashok K Saxena Prakash Gondode Geetanjali T Chilkoti Tusha Sharma Basu D Banerjee |
Title | Radiotherapy Metastatic Prostate Cancer Cell Lines Treated with Gold Nanorods Modulate miRNA Signatures |
Citation | International Journal of Molecular Sciences 2024. |
Authors | Sílvia Soares 1,2,3,4,5,6,7ORCID,Fátima Aires 7ORCID,Armanda Monteiro 7,Gabriela Pinto 7,Isabel Faria 2,3,Goreti Sales 5,6ORCID,Miguel A. Correa-Duarte 8,9ORCID,Susana Guerreiro 1,10,11,12,† andRúben Fernandes 1,2,3,13,*,† |
Title | CircPLXNB2 regulates acute myeloid leukemia progression through miR-654-3p/CCND1 axis |
Citation | Hematology 2023. |
Authors | Jiao Wang, Cuiping Wu and Weilun Zhou |
Title | The expression levels of circulating miR-140-3p, miR-130a-3p, and miR-320b as diagnostic biomarkers in acute ischemic stroke |
Citation | kaohsiung journal of medical sciences 2023. |
Authors | Hong-Yan Ju, Shan-Shan Tang, Bang-Jing Li, Xi Luo, Qi Li |